KAYA Pelin

: 0000-0003-4735-4116

Main Referenced Co-authors

ABANKWA, Daniel (3)

SCHAFFNER, Elisabeth (3)

MANOHARAN, Ganesh Babu (2)

Burgos, Maria (1)

GAIGNEAUX, Anthoula (1)

Main Referenced Keywords

cancer (2); drug development (2); cancer cell biology (1); K-Ras, PDE6D inhibitor, chaperone, prenylation, BRET, micro-tumor growth (1); KRAS (1);

Main Referenced Disciplines

Biochemistry, biophysics & molecular biology (4)

Publications (total 4)

Search in publications

The most downloaded

43 downloads

Steffen, C., Kaya, P., Schaffner-Reckinger, E., & Abankwa, D. (2023). Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society Transactions. doi:10.1042/BST20221343 https://hdl.handle.net/10993/55505

The most cited

7 citations (WOS)

KAYA, P. (2023). CHARACTERIZATION OF NOVEL INHIBITORS OF THE TRAFFICKING CHAPERONE PDE6D [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/58777

https://hdl.handle.net/10993/58777

KAYA, P., SCHAFFNER-RECKINGER, E., MANOHARAN, G. B., Vukic, V., Kiriazis, A., LEDDA, M., Burgos, M., PAVIC, K., GAIGNEAUX, A., GLAAB, E., & ABANKWA, D. (2023). An improved PDE6D inhibitor combines with Sildenafil to synergistically inhibit KRAS mutant cancer cell growth. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/58308. doi:10.1101/2023.08.23.554263

https://hdl.handle.net/10993/58308

Steffen, C., Kaya, P., Schaffner-Reckinger, E., & Abankwa, D. (2023). Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society Transactions. doi:10.1042/BST20221343

https://hdl.handle.net/10993/55505

Peer Reviewed verified by ORBi

KAYA, P., SCHAFFNER-RECKINGER, E., MANOHARAN, G. B., Saley, B., & ABANKWA, D. (18 October 2022). Novel High Affinity Inhibitors Of The K-Ras Trafficking Chaperone PDE6D [Paper presentation]. The Fourth RAS Initiative Symposium, Frederick, United States.

https://hdl.handle.net/10993/58942

Peer reviewed